ORGANOVO HOLDINGS INC
Filed Apr 12, 2024.
View on SEC.govAbout this filing
A company's registration of shares for sale to the public, often for a first offering. It describes the business, its risks and how the company plans to use the money.
period unavailable · Filed Apr 12, 2024
Contents
Capitalization
The following table sets forth our cash and cash equivalents and total capitalization as of December 31, 2023:
on an actual basis;
a pro forma basis to reflect (i) the issuance of an aggregate of 237,721 shares of common stock between January 1, 2024 and March 31, 2024 pursuant to the Sales Agreement with H.C. Wainwright & Co., LLC and JonesTrading Institutional Services LLC (the “Sales Agreement”) for net proceeds to us of approximately $0.3 million; and
on an as adjusted basis, giving effect to the issuance and sale of [] shares of common stock in this offering at the assumed public offering price of $[] per share, which is the last reported sale price of our common stock on the Nasdaq Capital Market on [__________], 2024, and after deducting placement agent fees and estimated offering expenses payable by us and assuming no sale of any pre-funded warrants in this offering.
The as adjusted information below is illustrative only, and our capitalization following the closing of this offering will be adjusted based on the actual public offering price and other terms of this offering determined at pricing.
You should read this information in conjunction with our financial statements and the related notes included elsewhere in this prospectus and in “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
| Actual(unaudited) · Proforma · Proforma as Adjusted | ||||
|---|---|---|---|---|
| (In thousands, except share and per share data) | ||||
| Cash and cash equivalents | $5,295 | $5,571 | $ | [ ] |
| Stockholders' equity: | ||||
| Common stock, par value $0.01 per share: 200,000,000 shares authorized, 9,838,755 shares issued and outstanding as of December 31, 2023, actual; 200,000,000 shares authorized,10,076,476 shares issued and outstanding, proforma; 200,000,000 shares authorized, [________] shares issued and outstanding, proforma as adjusted | $10 | $10 | $ | [ ] |
| Additional paid-in capital | 342,796 | 342,531 | [ ] | |
| Accumulated deficit | (336,624) | (336,624) | [ ] | |
| Accumulated other comprehensive loss | 1 | 1 | [ ] | |
| Treasury stock, 46 shares at cost | (1) | (1) | [ ] | |
| Total stockholders’ equity | 6,182 | 5,917 | [ ] | |
| Total capitalization | $6,182 | $5,917 | $ | [ ] |
The number of shares immediately outstanding following this offering is based on 9,838,755 shares of common stock outstanding as of December 31, 2023 and also gives effect to 237,712 shares of our common sold and issued through an “at the market offering”
pursuant to Sales Agreement and excludes:
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.